Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 307 is a processed pseudogene derived from the 5S ribosomal RNA gene. 5S ribosomal RNA itself is a small, highly conserved RNA component of the large ribosomal subunit, essential for ribosome structure and function, but pseudogenes such as RNA5SP307 do not produce functional ribosomal RNAs[1][2]. Processed pseudogenes generally arise through the integration of reverse-transcribed RNA into the genome, lack introns, and are usually transcriptionally inactive due to regulatory mutations[2]. While some pseudogenes have been reported to act as competitive endogenous RNAs or miRNA sponges, modulating gene regulatory networks, there is no evidence that RNA5SP307 fulfills any protein-coding or major regulatory function. Pseudogene expression profiles may have relevance in cancer classification and as molecular markers, but specific clinical roles for RNA5SP307 are not established[4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 307 (RNA5SP307).